PCVX
HOLD / NEUTRALMeanRevComposite
35.50
Technical
59.40
Fundamental
27.50
Rank
—
Price
60.81
Hurst
0.20
As of
Nov 4, 2026
Daily
Vaxcyte Inc
HEALTHCAREBIOTECHNOLOGYVaxcyte operates as an early-stage vaccine developer focused on creating immunizations against communicable illnesses for worldwide use. Based in Foster City, California, the company is currently in preclinical stages of research and development.
Market cap
$9.6B
P/E (trailing)
—
P/E (forward)
—
PEG ratio
—
Dividend yield
—
Beta
1.29
52w range
40.14 – 90.75
Return on equity
-36.50%
Profit margin
0.00%
Revenue growth
0.00%
Earnings growth
0.00%
Price history
1Y: 60.81 (+34.3%) · range 40.32–73.82
Cycle position
47/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 31 · NOT READY · exit proximity 0
Conviction
38/ 100 · maturity 71%
VScore.3232
Buildup.2363
EMA entry setup.2831
Fundamentals.1728
Volume profile
POC
56.66
Price vs POC
+7.3%
Overhead supply
41%
Runway
+0.7%
Value area 52.57–68.03 · 41% of 120d volume overhead · moderate overhead
Get an AI analyst's read on this ticker.Open the AI analyst
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.967 | Nov 4, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.